From the Journals

SEE Program Strengthens Adherence

Share

  • 1

    SEE trial improved glaucoma medication adherence.

  • 2

    235 adults participated.

  • 3

    Adherence increased from 64% to 78%.

  • 4

    55% of SEE participants achieved ≥80% adherence.

  • 5

    Reduced glaucoma-related distress significantly.

  • 6

    Incorporates personalized education via nonphysician coaching.

  • 7

    Supports the effectiveness of multifaceted interventions in chronic disease.

Original Source(s)

Related Content